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Detailed biochemical and biophysical characterization of viruses requires viral preparations16
of high quantity and purity. The optimization of virus production and purification is an17
essential, but laborious and time-consuming process. Asymmetric flow field flow18
fractionation (AF4) is an attractive alternative method for virus purification because it is a19
rapid and gentle separation method that should preserve viral infectivity. Here we20
optimized the AF4 conditions to be used for purification of a model virus, bacteriophage21
PRD1, from various types of starting materials. Our results show that AF4 is well suited for22
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PRD1 purification as monitored by virus recovery and specific infectivity. Short analysis23
time and high sample loads enabled us to use AF4 for preparative scale purification of24
PRD1. Furthermore, we show that AF4 enables the rapid real-time analysis of progeny25
virus production in infected cells.26
27
Highlights28
∑ Virus remained infectious during gentle AF4 analysis.29
∑ AF4 purification efficiently separated host-derived impurities and viruses.30
∑  AF4 purification yielded purity comparable to traditional ultracentrifugation31
methods.32
∑ Use of 250 µm spacer eliminated the dilution of lysate samples during AF4.33
∑ AF4 enables real-time analysis of progeny virus production in infected cells.34
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1. Introduction38
Viruses that infect animals and plants generally receive more attention than do viruses of39
prokaryotes (bacteria and archaea) because of their medical, agricultural, and economic40
importance. However, prokaryotic viruses have an immense effect on global microbial41
communities and consequently on Earth's biogeochemical cycles and climate [1-5]. The42
current estimate for virus abundance in sea water is ~1030 [1] and similar numbers have43
been proposed for soil [6]. Still relatively few prokaryotic viruses are known in molecular,44
structural, and biochemical detail. Such knowledge is essential for interpreting viral45
diversity at the genomic and structural level and for understanding viral roles in every46
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ecosystem. It is worth mentioning here that our current knowledge of many cellular47
processes, including transcription, translation, DNA replication, protein sorting, etc., stems48
from research on prokaryotic viruses. In addition, many commercially available enzymes49
vital for contemporary molecular biology, including ligases, restriction enzymes and50
polymerases, originated from prokaryotic viruses.51
52
Further basic and applied research on viruses requires samples of high purity in quantity.53
After optimised production, the first purification step typically involves precipitation or54
filtration [7, 8]. Precipitation is applicable to high sample volumes where it can55
simultaneously concentrate and purify the viruses [8]. Downstream purification steps to56
remove impurities that co-precipitate with the virus particles due to similar biophysical57
and/or biochemical properties most commonly involve ultracentrifugation [9, 10].58
Depending on the ultracentrifugation method used, virus purification is achieved based on59
its sedimentation coefficient (rate zonal), buoyant density (isopycnic), or flotation [10]. A60
final purification step, such as differential ultracentrifugation or ultrafiltration, removes the61
gradient material and concentrates the viruses.62
63
While ultracentrifugation methods often result in high purity virus preparations, recovery64
yields can be low [8] (see also Fig. S9). Therefore, preparative centrifugation of viruses65
requires expensive ultracentrifuge farms. Moreover, the viscous and hyperosmotic nature66
of some gradient media (e.g., sucrose, CsCl) combined with the strong shear forces67
generated during high speed centrifugation can damage viruses and lead to loss of68
infectivity [8]. Alternative methods have also been developed as reviewed in [8, 9]. Anion69
exchange chromatography using monolithic columns has proven efficient for purification of70
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large biomolecules such as viruses [11-13]. The macroporous nature of these monoliths71
provides high surface accessibility for large molecules [13]. However, elution by increasing72
ionic strength can be harmful to some sensitive viruses and is unusable in the case of73
halophilic viruses that require high salt concentrations for infectivity [14].74
75
Asymmetric flow field flow fractionation (AF4) is a subtechnique developed from field flow76
fractionation (FFF) methods. Its principles and theory have been described in the original77
papers [15] [16] [17] [18] and are summarized in many reviews [19-23]. In AF4, sample78
separation takes place in a trapezoidal flat channel under the influence of two flows: the79
channel flow (Vout) that has a parabolic profile and the cross-flow (Vc) that drives sample80
components towards the accumulation wall. This force is counteracted by the diffusion of81
sample components away from the wall. As a result, each sample component equilibrates82
at a distance from the accumulation wall that depends on its diffusion coefficient (D) and83
hydrodynamic molecular size [15, 16]. In the normal separation mode smaller sample84
components elute before larger ones.  Normal separation mode applies to sample85
components smaller than ~1 μm [20].86
87
The omission of the stationary phase in AF4 decreases the pressure and shear forces88
during separation. In addition, the mobile phase composition can be readily modified to89
meet the demands of the sample components. As a result, AF4 is a gentle separation90
method that enables the analyzed molecules to retain their native conformation. AF4 has91
been successfully applied to various types of biological specimens [20, 22, 24] as well as92
in studies of particles and colloids of non-biological origin [25]. Viruses were among the93
first specimens analyzed when field flow fractionation was introduced in 1976 [15]. Already94
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in 1977 symmetric field flow fractionation was applied to determine the diffusion95
coefficients of bacteriophages Qβ, f2, MS2, P22 and φX174 [26]. Nowadays, however,96
AF4 [16] has replaced symmetric flow field flow fractionation. It has been used to study the97
particle size, size distribution and particle counts of viruses [27, 28] and virus-like particles98
(VLPs) [29-32]. AF4 has also shown its potential for determining the changes in the size99
distribution of VLPs upon assembly from purified modified viral protein components as well100
as the effect of encapsidation of heterologous DNA [30, 31]. In addition, viruses have been101
utilized in experiments validating AF4 theory and performance [17, 18]. However, although102
the potent of AF4 for purification of macromolecules, such as viruses, has been103
recognized, no published reports on the utilization of AF4 for large scale virus purification104
exists.105
106
In this work, our goal was to develop a preparative scale fractionation procedure that107
would provide high purity accompanied by high yields of infectious viruses. We also108
compared AF4 to the established virus purification methods. We chose bacteriophage109
PRD1 [33] as our model virus as it already has an array of well-established purification110
methods [11, 34, 35] enabling comparisons on purification methods efficacy. PRD1 has an111
icosahedral, proteinaceous capsid with a diameter of ~66 nm and molecular mass of112
~66 MDa. Virions are decorated with ~20 nm spikes at the five-fold symmetry axes. An113
internal membrane lies just inside the protein shell and encloses the double-stranded DNA114
genome [36-39]. Here we determined the optimal AF4 operation conditions for PRD1 and115
analyzed its purification using various types of starting materials. We also combined AF4116
with monolithic anion chromatography. Both AF4 and monolithic anion chromatography117
were then compared to traditional ultracentrifugation methods. Our results demonstrate118
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that AF4 has great potential for the purification of infectious viruses. Furthermore, we show119
that AF4 enables rapid real-time analysis of progeny virus production in infected cells.120
121
2. Materials and methods122
2.1 Sample preparation123
Bacteriophage PRD1 was cultured and purified as previously described [35]. The host124
Salmonella enterica serovar Typhimurium LT2 DS88 [40] was grown in Luria-Bertani125
medium (LB) at 37 °C. Cells in logarithmic growth phase were infected using a multiplicity126
of infection (MOI) of 10. Cell lysis was detected by measuring culture turbidity at 550 nm127
(Chlormic, JP Selecta S.A., Barcelona, Spain). In specific cases, the culture was treated128
after lysis with DNase I (50 µg/mL; Sigma-Aldrich) or RNase A (30 µg/mL; Roche) for 1 h129
at 37 °C. Subsequent centrifugation (Sorval rotor SLA1500/3000, 8000 rpm, 20 min, 4 °C)130
removed cell debris to yield the cleared lysate. Viruses were precipitated from the lysate131
using 10% (w/v) polyethylene glycol (PEG) 6000 and 0.5 M NaCl, collected by132
centrifugation as above, and resuspended in a small amount of buffer (0.01 of the initial133
volume) to yield PEG-PRD1. Standard virus buffer (20 mM potassium phosphate [pH 7.2],134
1 mM MgCl2) was used in all purification steps. The resuspended viruses were purified by135
rate zonal centrifugation with a linear 5–20% (w/v) sucrose gradient (Sorvall rotor AH629,136
24 000 rpm, 55 min, 5 °C). Zones containing mature infectious viruses were collected by137
differential centrifugation (Sorvall rotor T647.5, 32 000 rpm, 3 h, 5 °C) and resuspended in138
virus buffer yielding 1xPRD1. Alternatively, further purification of the zones by an139
additional buoyant density centrifugation in 20-70% sucrose gradients (Sorvall rotor140
AH629, 24 000 rpm, 20 h, 15 °C) followed by differential centrifugation as above yielded141
2XPRD1 purified to homogeneity (see also Fig. S9A).142
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2.2 AF4 instrumentation and its operation144
The AF4 experiments were carried out using an AF2000 MT instrument (Postnova145
Analytics, Landsberg, Germany) equipped with a solvent organizer (PN7140), a solvent146
degasser (PN7520), two isocratic high performance liquid chromatography (HPLC) pumps147
for generation of carrier flow (PN1130), a syringe pump (Kloehn v6) for controlling cross-148
flow, a purging port (PN1610) for rinsing, a manual injection valve (Rheodyne 9725i), a149
temperature controlled AF4 channel oven for sample fractionation (PN4020), preparative150
flow cell for UV (PN3211-003), and a fraction collector (PN8050). AF4 operation and data151
collection were carried out using Postnova AF2000 software. Separations were performed152
at 22 ºC in a channel that contained a 350 μm or a 250 μm spacer. The channel had a tip-153
to-tip length of 27.5 cm, initial width 2.0 cm, and final width of 0.5 cm. A regenerated154
cellulose (RC) membrane with molecular weight cut-off (MWCO) value of 100 kDa (Z-155
MEM-AQU-529, Postnova) was used unless otherwise mentioned. The injection volume156
was 20-1000 μl. Prior to sample injection, aggregated material was removed by157
centrifugation (Eppendorf centrifuge 5415D, 10 000 g, 5 min). The outlet flow was158
monitored at 260 or 280 nm using an inline variable wavelength detector (Shimadzu SPD-159
20A; Shimadzu, Kyoto, Japan) with detector range settings as appropriate for each input160
sample concentration.161
162
Standard viral buffer (see above 2.1) served as the AF4 mobile phase. Vout was 0.2 ml/min163
unless otherwise mentioned. Focusing was performed applying the same cross-flow that164
was used for fractionation. Focusing time varied from 10-30 min depending on the amount165
and the expected polydispersity of the injected sample. Between successive AF4166
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experiments, material retained in the channel was removed by rinsing the channel without167
cross-flow until the UV signal reached the baseline. Repeatability was confirmed with at168
least three technical repetitions and using various specimen preparations (biological169
replicates). Fractions (0.5-1 ml) were collected from the start of the elution phase and170
stored at 4 °C.171
172
Collection of UV-multi angle light scattering (MALS) data was performed with a second173
AF2000 MT instrument (Postnova Analytics, Landsberg, Germany) that was equipped with174
an analytical flow cell for UV (PN3211-003), a refractive index (RI) detector (PN3150) and175
MALS detector (PN3621) equipped with a green laser (532 nm emission wavelength). Tf176
was 4 min. Elution was performed with Vout of 0.5 ml/min. The 25 min linear elution177
gradient to 0.28 ml/min was followed by a 15 min exponential step to final elution at 0.08178
ml/min. MALS data provided the radius of gyration (Rg), which was calculated from179
measured signal intensities by applying the following intensity distribution function P(ϑ).180
The mature virion of PRD1 has an icosahedral shape [37]. Assuming a spherical shape,181
the radius of gyration of the PEG-PRD1 virus particles was determined according to:182
( ) = ( ( ℎ − ℎ ℎ)) (1)183
with184
ℎ = (2)185
P hereby represents the scattering form factor describing the angular dependence of the186
intensity of the scattered light, ϑ the observed angle, η the refractive index of the solvent187
medium and λ the wavelength of the incident laser light. Based on the obtained radius of188
gyration, the geometric diameter (Dgeo) of icosahedral (spherical) virus particles was189
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calculated using the formula Dgeo=2 × √3 ÷ 5 × . ). The size distribution of the virus190
particle aggregates was determined via a random coil model.191
192
2.3 Monolithic chromatography193
Chromatographic experiments were carried out at room temperature using an ÄKTA194
Purifier 10 UPC (GE Healthcare, Uppsala, Sweden) liquid chromatography system195
operated by Unicorn 5.2 software (GE Healthcare, Uppsala, Sweden). A CIM-QA 1 ml-196
monolithic column (BIA Separations, Slovenia) was used for purification of PRD1 as197
previously described [11]. AF4 fractions containing the virus were pooled and centrifuged198
(Eppendorf centrifuge 5415D, 13 000 rpm, 10 min) prior to loading on the column.199
Supernatant was injected using a 5 ml loop. The chromatography was performed at a flow200
rate of 1 ml/min using the virus buffer (see 2.1). After sample loading, unbound material201
was removed by extensive washing with at least 20 column volumes or until the A260202
reached the baseline. Elution was performed with a linear 0 – 1.5 M NaCl gradient in 20203
column volumes using the virus buffer supplemented with 2 M NaCl. Columns were204
washed by raising the NaCl concentration to 2 M. The absorbance at 260 nm was205
continuously monitored and 0.5 or 1 ml fractions were collected. Chromatography was206
repeated three times.207
208
2.4 Assay of purified viruses: number of infectious viruses, protein amount, purity and yield209
Protein concentration was measured by Bradford assay [41] using a microplate reader210
(Thermo Scientific, Fair Lawn, NJ, USA) and bovine serum albumin (BSA) as a standard,211
or by measuring A260 and A280 values (Eppendorf Photometer, Hamburg, Germany). The212
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number of infectious viruses (plaque forming units, PFU) was determined by plaque assay.213
Recoveries (%) were calculated from protein amount or PFU using the formulas:214
[100%*(∑A280,fractions)/ A280,injected sample], [100%*(∑μg proteinfractions)/μg proteininjected sample] or215
[100%*(∑PFUfractions) / PFUinjected sample].216
217
To assess protein content, AF4 fractions or viral input lysates were treated with ~10%218
trichloroacetic acid (TCA, v/v) on ice for 30 min. The precipitated proteins were collected219
by centrifugation (Eppendorf centrifuge 5415D, 13,000 rpm, 30 min, 4 ºC) and220
resuspended in 1.5× SDS-PAGE sample buffer [42]. Boiled samples were analyzed in221
SDS polyacrylamide (SDS-PAGE) gels made in-house that used 16% acrylamide in the222
separation gels [42]. Proteins were visualized with Coomassie stain. Protein ladders223
(#26614 or #26616, Thermo Scientific, Fair Lawn, NJ, USA) were used as size markers.224
Gels were documented using ChemiDoc (Bio Rad, Hercules, USA).225
226
3. Results and discussion227
228
3.1. Evaluation of AF4 conditions for purification of PRD1229
Detailed guides to design of AF4 protocols have been published [19, 43]. Adjustment of230
several parameters is necessary for optimal separation and yield. These include flow rates231
(focusing, channel, and cross-flow), focusing and elution times, the elution gradient profile232
(constant, linear, exponential, or step-wise), ultrafiltration membrane (material and233
MWCO), channel volume (spacer height, width, channel length), and mobile phase234
composition (conductivity, pH, surfactants). Importantly, these parameters have235
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interdependent effects on AF4 performance. Consequently, the selected AF4 operation236
conditions are always compromises between separation, purity, dilution, and yield. We237
performed a set of experiments with varying conditions and sample types to find the238
optimal purification process for our model virus PRD1. Purity and infectivity of collected239
fractions were monitored by measuring protein concentration and the number of infectious240
viruses, and from that calculating the specific infectivity. Protein contents were visualized241
in Coomassie-stained SDS-PAGE gels.242
243
3.1.1. Ultrafiltration membrane-virus interaction244
The RC membrane with a 10 kDa MWCO is most commonly used for analysis of biological245
macromolecules [44, 45]. Previous comparison of RC (10 kDa MWCO), triacetate246
cellulose, and polyethersulphone membranes showed the highest recovery of negatively247
charged VLPs with RC [46]. We chose instead the RC membrane with a 100 kDa MWCO248
to allow impurities less than 100 kDa to pass through. RC has low isoelectronic point and249
thus negative charge at neutral pH [47, 48]. Thus, the charge of sample components can250
induce attractive or repulsive interactions leading to reduced recoveries and unexpected251
elution behaviour. In addition, the pore density of membranes affects recoveries. High pore252
density enables the entry of sample components to the pores and may reduce the253
recoveries [49].254
255
To test for the potential attractive or repulsive interactions with the 100 kDa membrane, we256
compared the UV signal intensities of fractograms obtained when 1xPRD1 samples were257
eluted in the presence versus absence of cross-flow (Fig. S1A). In both cases, virus eluted258
as a single sharp peak of similar intensity (Fig. S1B) and the sum of A280 values of the259
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peak regions were nearly identical with the input sample (Fig. S1C). This demonstrated260
that the virus particles were not significantly attracted to the membrane. This is in line with261
the successful purification of PRD1 using anion exchange columns [11, 34] that suggested262
the binding of negatively charged regions of PRD1 virions to the anion exchange matrix.263
Since there was a significant difference in the retention times (tr) of runs performed in the264
presence versus absence of cross-flow, we concluded that repulsive forces between265
virions and the membrane were not strong enough to cause elution of the virus in the void.266
Due to their relatively large sizes, virions are usually well retained in the AF4 channel and267
elution at cross-flow rates close to zero is typical for channels with 350-380 μm theoretical268
thickness [26, 27, 29]. PRD1 particles started eluting when the cross-flow had declined to269
~0.2 ml/min (Fig. S1B, see also Fig. 1B).270
271
3.1.2. Influence of focusing time272
Focusing time (tf) affects sample recovery, resolution, and analysis time. Too short a time273
results in incomplete equilibration and an increased mean layer thickness of the sample274
zone. As a result, sample components are eluted across a larger range of flow velocities275
which results in suboptimal resolution, band broadening, and potential elution in the void.276
An extended focusing period allows more time for potential attractive interactions between277
sample components, as well as between the sample and the membrane, which can induce278
sample aggregation and reduced recoveries [21, 50].279
280
To optimise the tf for PEG-PRD1 samples, we tested 5, 10, and 15 min times combined281
with a 10 min linearly decaying cross flow gradient from 1 ml/min to 0.1 ml/min (Fig. 1A). In282
addition to virions, a PEG-PRD1 sample contains host-derived impurities that co-283
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precipitate with virus particles during PEG-NaCl precipitation. Therefore, we expected to284
see a more complex fractogram compared to the single elution peak observed for partially285
purified 1xPRD1 (Fig. S1B). Here two peaks followed the void peak (V0): the first peak had286
low signal intensity, whereas the second displayed a tr of ~18 min (Fig. 1B), a value close287
to that of 1xPRD1 (~14 min in Fig. S1B). Increasing the tf from 5 to 10 or 15 min reduced288
the V0, but did not have a significant effect on other peak intensities (Fig. 1B). A decreased289
V0 usually results from better retention of small molecules [29]. Here, since molecules290
smaller than 100 kDa passed through the accumulation wall, no changes in signal291
intensities of the first peak was detected. However, as the separation of the void peak from292
other peaks was slightly improved with longer tf, 10 or 15 min were preferred for higher293
sample loads or with heterogeneous and polydisperse samples.294
295
Pooled fractions representing both peaks were analyzed by denaturing SDS-PAGE gels296
(Fig. 1C). The first minor peak showed the presence of proteins ranging from high ~200297
kDa to low ~12 kDa molecular weights, whereas the second major peak was enriched with298
PRD1 specific proteins. The 37 genes in the PRD1 genome include 18 that encode protein299
components of mature virions [51]. They range in size from ~5 kDa (P20) to ~64 kDa (P2).300
Each virion contains 240 trimers of the ~43 kDa major coat protein (P3) [37, 51].301
Consequently, this protein was visibly the most abundant protein species in the SDS-302
PAGE gel for second peak (Fig. 1C). Hereafter, we refer the peak with tr ~18 min as the303
virus peak.304
305
While many impurities were removed from the virus sample during AF4, some high306
molecular weight contaminants remained. Likewise, even though a 100 kDa MWCO307
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membrane was used, protein species smaller than 100 kDa were observed in the first308
peak. This suggested that they were released from larger protein complexes during either309
AF4 or denaturing SDS-PAGE analysis. Control experiments using protein standards of310
150, 225, 447, and 669 kDa revealed peak retention times of 4.3, 4.9, 5.6, and 6.8 min,311
respectively (Fig. S2A), while a mixture of 225 and 447 kDa proteins eluted as a single312
peak (Fig. S2B). Under the same elution conditions, the tr of the first peak in the PEG-313
PRD1 fractogram was ~8 min. This confirmed that the first peak for PEG-PRD1 contained314
high molecular weight proteins and macromolecular complexes that could not be315
separated by the used AF4 analysis conditions.316
317
3.1.3. Effect of flow rates318
Cross-flow strength has the greatest impact on AF4 separation efficiency [21]. High Vc319
improves separation, but at the cost of increased dilution and possible membrane320
interactions. High molecular weight analytes are more prone to dilution [50]. Experimental321
testing is required to determine the optimal Vc for best separation and recovery. Virions are322
well retained in the channel and require rather slow Vc for their fractionation [26, 27, 29].323
For 1xPRD1 we tested linear 10 min gradients in which initial Vc rates of 0.5, 0.75, 1.0, or324
1.5 ml/min were decreased to 0.1 ml/min (Fig. S3A). PRD1 particles eluted as a single325
peak in all cases. As expected, higher Vc showed increased tr (Fig. S3B) due to sample326
components equilibrating in regions of lower laminar flow velocity closer to the327
accumulation wall [50]. The lowest Vc resulted in the lowest peak intensity, whereas 1.0328
and 1.5 ml/min rates resulted in comparable peak intensities (Fig. S3B).329
330
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Comparison of two Vout rates (0.2 and 0.5 ml/min) and two Vc rates (1.0 and 1.5 ml/min) on331
separation of PEG-PRD1 sample components did not show significant change in332
separation of the two peaks, in their signal intensities, or in recoveries of infectious viruses,333
but higher Vout reduced the analysis time by ~10 min (Fig. S4A-C). Finally we compared334
the combination of flow rates that provided a Vc/Vout ratio of 5: i) Vc: 1.0 ml/min and Vout:335
0.2 ml/min; ii) Vc: 2.5 ml/min and Vout: 0.5 ml/min; and iii) Vc: 2.0 ml/min and Vout: 0.4336
ml/min. As expected, tr was approximately the same for all three combinations, while337
increased flow rates did not improve resolution but reduced signal intensities (Fig. S4D).338
339
3.1.4. Influence of elution gradient type340
Our initial AF4 conditions did not result in baseline separation of the peaks for the PEG-341
PRD1 sample, and also some high molecular weight complexes co-fractionated with the342
virions (Figs. 1). We investigated whether different step gradient types would improve the343
separation. The best resolution and consequent increase in specific infectivity correlated344
with longer elution time rather than with the gradient type (Fig. S5 and Fig. 2A). The345
absorbance measurements (Fig. 2B) and intensities of protein patterns in SDS-PAGE gels346
(Fig. 2C) correlated with the peak positions in the fractograms. Although the first peak347
eluted as a single peak, gel analysis of fractions 1-5 showed that it contained high348
molecular weight proteins and macromolecular complexes of various compositions eluting349
at different Vc rates. In summary, many host protein contaminants were separated from the350
virus fractions during AF4, but some high molecular weight impurities still co-fractionated351
with the virus (Fig. 2C, compare lanes 1-5 with lanes 6-8) that could be partially attributed352
to the fact that virus eluted at the end of cross flow gradient.353
354
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The two fractions from both the first and second peak having the highest A280 values were355
pooled (fractions 2-3 corresponding to 5-15 min, and fractions 6-7 corresponding to 25-35356
min, respectively) and their virus and protein contents were assayed to evaluate the357
biological activity of the virus, recovery yields, and purity (Table 1). Although the UV signal358
did not reach the baseline between the peaks (Figs. 2A and 2B), the more than 1000-fold359
difference in their virus contents indicated good separation (Table 1). The specific360
infectivity of the virus was improved ~7-fold compared to the analysed input PEG-PRD1361
sample. Yields calculated from the infectious virus amounts indicated that ~50% of the362
virus was recovered in those two pooled fractions 6 and 7 from the second peak. While363
higher yields could have been obtained by pooling more fractions, this would have364
increased the total volume and thereby decreased the virus concentration.365
366
Total protein yields were significantly lower than that obtained for infectious viruses367
verifying that many host proteins were removed from the input sample through their368
passage through the 100 kDa membrane (Table 1). Absorbance measurements at 280 nm369
reflect not only protein concentration, but also nucleic acids that absorb at 280 nm370
although their absorbance maximum is at 254 nm. The Bradford assay is specific for371
proteins, but the reagent reacts preferentially with certain amino acid residues. Therefore,372
the observed differences in the recovery between these two assays was most probably373
due to variation in the nucleic acid and protein pools present in these fractions.374
375
The higher A260/A280 ratio of the first peak relative to the virus peak suggested increased376
nucleic acid concentration in the first peak (Fig. 2B). PEG-NaCl treatment is known to377
precipitate not only proteins, but also DNA and ribosomes [7, 52]. Plant ribosomes378
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analysed using similar AF4 elution conditions (i.e., linear cross flow gradient from 1 ml/min379
to 0 ml/min, Vout 0.2 ml/min) started to elute at a Vc rate of ~0.8 ml/min [53]. Since380
prokaryotic ribosomes (~2.3 MDa) are ~1.2 MDa smaller than eukaryotic ones [54],381
ribosomes present in PEG-PRD1 precipitates would be expected to start eluting at higher382
Vc rates. Consequently, they should start eluting in the first peak. In denaturing conditions383
prokaryotic ribosomes dissociate to yield three rRNA species and 54 ribosomal proteins384
that are less than 50 kDa, which could account for some of the small protein species385
observed in SDS-PAGE gels (Fig. 2C). Pretreatment of PRD1 lysate with DNase I or386
RNase A prior to PEG-NaCl precipitation significantly reduced the intensity of the first387
peak, confirming that the first peak contained nucleic acids and/or nucleoprotein388
complexes (Fig. S6). In general, our AF4 analyses showed that the intensity of the first389
peak relative to the virus peak varied between different PEG-PRD1 sample preparations390
(compare Figs 1, 2, S2, S4 and S5).391
392
3.2. AF4 analysis of PRD1 lysates393
AF4 has been used to measure total virus particle counts from crude vaccines produced in394
infected embryonated chicken eggs and cell culture supernatants [28, 29]. This suggested395
that AF4 had the potential to provide easy and fast purification of PRD1 directly from396
lysates of infected host cell cultures. AF4 analysis of crude PRD1 lysates resulted in two397
peaks having similar retention times to those from PEG-PRD1 (Fig. 3A, see also Fig. 2A).398
The significantly higher intensity of the first peak relative to the second peak indicated the399
expected large quantity of impurities in the lysate (Figs. 3A and B). Virus-induced cell lysis400
releases the host cell contents including a cocktail of degrading enzymes (proteases,401
nucleases, lipases) into the culture media. Thus, the amount of host nucleic acids, proteins402
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and macromolecular complexes present in the lysate will vary depending on the time of403
sampling and is expected to increase as the lysis proceeds and to decrease during404
storage due to degradation of sample components. This explained the variation in the ratio405
of the first and the second peak intensities among sample preparations (Figs. 3A, 4C, and406
S8C). Virus purity was verified by SDS-PAGE analysis of fractions (Fig. 3C). Importantly,407
AF4 fractionation recovered approximately half of the virus in the input sample while408
improving its specific infectivity approximately ten-fold (~5×1012 PFU/mg protein)409
compared to the input lysate sample (Table 2). The only drawback was the relatively low410
virus concentration in the input lysate and further ~7-fold dilution that occurred during the411
fractionation process (Table 2). Consequently, due to low virus concentration in the input412
bacterial lysates, the amount of virus that could be produced by a single AF4 purification413
was low, ~12 μg, unless several subsequent experiments were performed.414
415
3.3 AF4 as a tool to analyze virus infection416
Encouraged by the purification results obtained for PRD1 lysates, we tested whether AF4417
could be used to monitor the progress of virus infection in terms of the release of infectious418
viruses. This is commonly done by classical one-step growth curve analysis, where virus-419
induced host cell lysis is detected as a decrease in the turbidity of the host cell culture (Fig.420
4A). Lysis coincided with an increase in the number of infectious progeny viruses in the421
lysate that needs to be determined with a separate plaque assay. Here we used AF4 to422
analyze supernatants collected from non-infected (Fig. 4B) and infected cultures (Fig. 4C)423
at various times post infection (p.i.). Fractograms from non-infected cells and those from424
early time points (1 and 20 min p.i.) for the PRD1-infected culture did not differ significantly425
from the baseline obtained for LB growth medium (Figs. 4B and C, right y-axis), indicating426
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that the amount of exported proteins and macromolecular complexes were below the427
detection limit. The appearance of two peaks in the fractograms correlated with the onset428
of virus-induced cell lysis that was visible at 115 min p.i. (Fig. 4A). Peaks increased in429
intensity as lysis proceeded, but also the shapes of the peaks differed to some extent (Fig.430
4C). The increasing number of free infectious viruses (Fig. 4D) correlated with the431
increasing intensity of the second peak in the fractograms (Fig. 4C). Virus concentrations432
in the first and second peak differed by approximately three orders of magnitude indicating433
good separation (Fig. 4D). Approximately 30-40% of the infectious input virus was434
recovered from the latest time point samples (115 and 185 min p.i.), but the concentration435
of the recovered viruses were 2- to 3-fold lower than that of the input sample lysate (Fig.436
4D).437
438
Dilution during the fractionation can be decreased by using a thinner spacer [16, 50]. We439
repeated the PRD1 one-step growth curve analysis using a 250 μm spacer (Fig. S7)440
instead of the 350 μm one used previously. The virus peak eluted at Vc of ~0.5 ml/min441
(Fig. S7C). Importantly, virus concentrations in the input sample and virus fractions from442
later time points were similar (Fig. S7D) showing that careful timing of fraction collection443
combined with reduced channel thickness can result in minimal sample dilution.444
Furthermore, as the consequence of decrease in sample volume the specific infectivity445
was improved two-fold. Overall, our results show that AF4 provides a rapid tool that can be446
used to identify the optimal conditions for virus production.447
448
3.4. Influence of sample load449
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Since we intend to use AF4 to purify different viruses from samples having low, medium,450
and high virus concentration, we tested the minimum and maximum sample loading451
capacity consistent with good resolution and recovery. Our initial test included a series of452
ten-fold dilutions of the 1xPRD1 sample (~1.4×1014 PFU/ml, 4×1012 PFU/mg protein).453
Technical repetitions produced fractograms having similar intensities and shapes except454
for the lowest amount of 1xPRD1 tested (0.3 μg, 1.4×109 PFUs) (Fig. 5A). Higher sample455
loads increased the tr by ~one minute. Peak shapes remained regular up to 3 mg of456
1xPRD1, beyond which point the peaks broadened, acquired a tail, and started to show457
spikes. SDS-PAGE gel analysis of pooled virus peak fractions showed the expected458
pattern for PRD1 proteins (Fig. 5B). Further screening revealed that the detection limit for459
the preparative UV-cell was ~1 μg of 1xPRD1, which corresponded to ~5 × 109 PFUs460
(data not shown). The previously reported detection limit for an analytical UV cell was461
~4×106 particles for influenza virus and ~2 μg of virions for Murine polyoma virus [27]. In462
summary, the linear working range was wide, from 1 μg up to ~3 mg, corresponding to463
~5×109 to ~1×1012 PFUs.464
465
When virus recovery yields and specific infectivities were determined here for 1xPRD1466
samples (Table 3) [11, 34, 40], even the highest input sample amounts tested showed467
good recovery of infectious viruses (~60% to ~80%), whereas lower sample amounts468
reduced recovery yields. Separate comparison of the main peak and the tail region from a469
3 mg 1xPRD1 sample showed comparable specific infectivities of 6.8×1012 and 3.3×1012470
PFU/mg protein, indicating that the tail region was not enriched with inactivated virus471
aggregates. That the fractionation did not significantly alter the specific infectivity of the472
input sample (~4×1012 PFU/mg) indicated that samples from upstream purification steps473
might be better suited for purification by AF4. Therefore, the maximal loading capacity for474
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PEG-PRD1 was also determined. Input samples of less than ~1 mg (corresponding to ~8475
× 1011 PFUs) yielded fractogram peaks that were regular in shape (Figs. 1B, S4A),476
whereas higher sample loads resulted in the characteristic virus peaks having spikes (see477
Fig. 2A, S5B) and a broader tailed virus peak. As the concentration of infectious viruses in478
lysates was ~10-100-fold lower than in PEG-PRD1 or 1xPRD1, a maximum volume of 1 ml479
analysed here (~2 – 4×1011 PFUs) was efficiently separated (Figs. 3, 4, S4D, S6A, and480
S7C).481
482
3.5. Particle size determination for PEG-PRD1483
To investigate the size distribution of particles present in the PEG-PRD1 samples,484
samples pretreated with DNase I were fractionated using an AF4 instrument equipped with485
MALS, RI, and UV detectors. To improve the separation of virus particles from any486
aggregates present in the PEG-PRD1 samples, the already established AF4 method was487
slightly modified by increasing the Vout rate to 0.5 ml/min and exponentially decreasing the488
Vc at the end of elution. The resulting measurements showed good repeatability (Fig. 6A).489
The main peak monitored by UV at 260 nm eluted between ~18-23 min, followed by the490
elution of larger particles and aggregates starting from ~28 to ~60 min. Measurement of491
infectious viruses from collected fractions confirmed the presence of viruses in the main492
peak. The measured intensity distribution profiles for the main peak showed an excellent493
agreement  with the applied spherical model (Equation (1) (Fig. S8). By these means, not494
only a radius of gyration of 24.5 ± 1.3 nm across the virus peak was determined indicating495
that the virus particles were homogeneous in size (Fig. 6B), but also the spherical496
(icosahedral) shape of PRD1 particles could be confirmed (Fig. S8). Conversion of the497
obtained radius of gyration into a geometric diameter of 63.2 ± 3.2 nm thereby showed498
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good correlation with the previously reported dimensions of PRD1 [37]. The size499
distribution of the aggregates was determined via a random coil model (Fig. 6B). However,500
due to the lack of fitting of the experimental data to the random coil model or any other501
available models (data not shown), the presented sizes are only rough estimates.502
503
3.6. AF4 as the first step in tandem, ultracentrifugation-free virus purification protocol504
AF4 purification of viruses from complex mixtures of host-derived impurities had some505
drawbacks. First, some large protein complexes co-eluted with the virus, especially in the506
case of PEG-PRD1 samples (see Fig. 2). Second, maximizing virus recovery by pooling507
more fractions results in greater virus dilution due to increased total volume. Therefore, we508
included monolithic anion exchange chromatography as an additional downstream509
purification step to potentially remove the large impurities and to concentrate the sample.510
The previously published protocol for monolithic chromatography purification of PRD1 [11]511
was followed here. For this tandem purification, PEG-precipitated sample was fractionated512
with AF4, and then all virus peak fractions were pooled and further purified using CIM QA513
monolithic columns. Chromatograms showed the presence of a minor peak (A280) followed514
by a main peak that eluted at 0.5 M NaCl (Fig. 7A), the previously reported NaCl515
concentration for PRD1 elution [11]. Analysis of the protein content in SDS-PAGE gels516
confirmed that peak fractions contained virus proteins accompanied by relatively few517
impurities (Fig. 7B). Virus titers in the fractions were high (1.4 – 5.5×1012 PFU/ml) and518
correlated with total protein concentration (Fig. 7C). Consequently, the specific infectivity519
of virus fractions was improved ~5-fold compared to the AF4-purified input sample (Table520
4), confirming the visual observation from Coomassie stained SDS-PAGE gels. Based on521
Bradford protein assays, ~33% of the input protein was recovered, whereas plaque assays522
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showed full recovery of the input virus (Table 4). Repeats of this tandem purification523
consistently yielded ~50% and ~60% recovery of protein and virus, respectively.524
Previously reported recoveries for various bacteriophages purified utilizing monolithic525
chromatography vary between 35 and 100% [11, 12]. A subsequent differential526
ultracentrifugation followed by resuspension of the virus pellet to small amount of buffer527
was utilized to remove the salt and to reduce the sample volume. Although this step528
increased the virus and protein concentrations, there was no change in the specific529
infectivity. Virus recovery averaged ~40%.530
531
For comparison with AF4 and tandem AF4-monolithic chromatography protocol, we also532
purified PRD1 using the traditional ultracentrifugation method [40], where PEG-PRD1 was533
purified by sequential rate zonal and density gradient centrifugations in 5-20% and 20-70%534
sucrose gradients followed by differential centrifugation to remove sucrose and to535
concentrate the sample—a procedure that takes two working days. The average virus536
concentration of the purified 2xPRD1 sample was high (~1.8×1014 PFU/ml), average yield537
was ~23%, and specific infectivity was ~1.9×1013 PFU/mg protein (Fig. S9). The average538
virus concentration of the 1xPRD1 sample was ~3.1×1014 PFU/ml), average yield was539
~31%, and specific infectivity was ~1.5×1013 PFU/mg protein, respectively. Therefore, our540
tandem AF4 and monolithic chromatography method yielded virus with comparable purity541
with 2xPRD1 in a similar amount of time, whereas AF4 alone resulted in specific542
infectivities approximately one order of magnitude lower with comparable purity with543




We used the model bacteriophage PRD1 [33] to investigate the potential of AF4 for the547
purification of complex and relatively large viruses. The complex PRD1 virion comprises a548
~66 nm diameter protein capsid that is decorated with ~20 nm spikes, within which lies the549
viral genome enclosed within a membrane [36-39]. Our studies demonstrated that AF4 is550
well suited for production of PRD1 preparations that possess both high purity and551
infectivity. The recovery yields varied from ~40 % upwards to full recovery. However,552
increased yield often came at the cost of increased sample dilution and lower virus553
concentration, whereas increased specific infectivity incurred some decrease in virus554
recovery.The greatest increase in specific infectivity was observed when starting with the555
least purified input materials, i.e., bacterial cell lysates. However, the specific infectivity556
achieved for both the lysate and the PEG-precipitated virus approached to that reported557
previously for PRD1 purified by rate-zonal ultracentrifugation (1xPRD1) [11, 40]. The use558
of thinner 250 μm spacer or the use of AF4 in conjunction with CIM anion chromatography559
allowed us to counteract dilution taking place during AF4. Consequently, the combination560
of AF4 and monolithic chromatography provides an effective method for large scale virus561
purification and is applicable to other types of macromolecular complexes as well.562
563
AF4 also proved to be a rapid tool to analyse the virus content released from the infected564
cells. These include optimization of the virus amount (MOI) used for infecting the host,565
selection of host producing the highest amount of viruses or producing the minimum566
amount of contaminating host proteins that could interfere with the purification process,567
finding the optimal growth conditions for maximal virus production, and determining the568
best time for collecting the viruses for further purification. In addition, AF4 showed potential569
to be used for studies on virus attachment on host cells as well as on the studies of virus570
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exit from infected cells. Finally, AF4 provides a rapid tool to produce virus material from571
lysates for initial biochemical and -physical characterisation of viruses.572
573
5. Acknowledgements574
The authors acknowledge the support of the employees and the use of experimental575
resources of Instruct. We thank Academy of Finland (funding grant 272853) and University576
of Helsinki for the support to EU ESFRI Instruct Centre for Virus Production (ICVIR) used577
in this study. This study was supported by Academy Professor (Academy of Finland)578
funding grants 283072 and 255342 (D.H.B.). Soile Storman, Helin Veskiväli, Hanna579
Seppälä, and Sari Korhonen are thanked for excellent technical assistance.580
581
6. References:582
[1] C.A. Suttle, Marine viruses-major players in the global ecosystem, Nat Rev Microbiol. 5 (2007) 801-812.583
[2] R. Danovaro, C. Corinaldesi, A. Dell'anno, J.A. Fuhrman, J.J. Middelburg, R.T. Noble, C.A. Suttle, Marine584
viruses and global climate change, FEMS Microbiol Rev. 35 (2011) 993-1034.585
[3] F. Rohwer, R.V. Thurber, Viruses manipulate the marine environment, Nature. 459 (2009) 207-212.586
[4] V.R. Després, J.A. Huffman, S.M. Burrows, C. Hoose, A.S. Safatov, G. Buryak, J. Fröhlich-Nowoisky, W.587
Elbert, M.O. Andreae, U. Pöschl, Primary biological aerosol particles in the atmosphere: a review, Tellus B.588
64 (2012) 1-58.589
[5] R.E. Anderson, W.J. Brazelton, J.A. Baross, The deep viriosphere: assessing the viral impact on microbial590
community dynamics in the deep subsurface, Rev Mineral Geochem. 75 (2013) 649-675.591
[6] S. Srinivasiah, J. Bhavsar, K. Thapar, M. Liles, T. Schoenfeld, K.E. Wommack, Phages across the592
biosphere: contrasts of viruses in soil and aquatic environments, Res Microbiol. 159 (2008) 349-357.593
[7] K.R. Yamamoto, B.M. Alberts, R. Benzinger, L. Lawhorne, G. Treiber, Rapid bacteriophage sedimentation594
in the presence of polyethylene glycol and its application to large-scale virus purification, Virology. 40595
(1970) 734-744.596
[8] L. Pedro, S.S. Soares, G.N. Ferreira, Purification of bionanoparticles, Chem Eng Technol. 31 (2008) 815-597
825.598
[9] M.W. Wolf, U. Reichl, Downstream processing of cell culture-derived virus particles, Expert Rev599
Vaccines. (2011).600
[10] J.E. Lawrence, G.F. Steward, Purification of viruses by centrifugation, in: W.M.G. Wilhelm S.W., and601
Suttle C.A. (Ed.) Manual of Aquatic Viral Ecology. ASLO, American Society of Limnology and Oceanography,602
2010, pp. 166-181.603
[11] H.M. Oksanen, A. Domanska, D.H. Bamford, Monolithic ion exchange chromatographic methods for604
virus purification, Virology. 434 (2012) 271-277.605
26
[12] E.M. Adriaenssens, S.M. Lehman, K. Vandersteegen, D. Vandenheuvel, D.L. Philippe, A. Cornelissen,606
M.R. Clokie, A.J. García, M. De Proft, M. Maes, CIM® monolithic anion-exchange chromatography as a607
useful alternative to CsCl gradient purification of bacteriophage particles, Virology. 434 (2012) 265-270.608
[13] A. Podgornik, S. Yamamoto, M. Peterka, N.L. Krajnc, Fast separation of large biomolecules using short609
monolithic columns, J Chromatogr B. 927 (2013) 80-89.610
[14] N.S. Atanasova, H.M. Oksanen, D.H. Bamford, Haloviruses of archaea, bacteria, and eukaryotes, Curr611
Opin Microbiol. 25 (2015) 40-48.612
[15] J.C. Giddings, F. Yang, M.N. Myers, Flow-field-flow fractionation: a versatile new separation method,613
Science. 193 (1976) 1244-1245.614
[16] K.G. Wahlund, J.C. Giddings, Properties of an asymmetrical flow field-flow fractionation channel having615
one permeable wall, Anal Chem. 59 (1987) 1332-1339.616
[17] A. Litzen, K.G. Wahlund, Zone broadening and dilution in rectangular and trapezoidal asymmetrical617
flow field-flow fractionation channels, Anal Chem. 63 (1991) 1001-1007.618
[18] A. Litzen, Separation speed, retention, and dispersion in asymmetrical flow field-flow fractionation as619
functions of channel dimensions and flow rates, Anal Chem. 65 (1993) 461-470.620
[19] J. Gigault, J.M. Pettibone, C. Schmitt, V.A. Hackley, Rational strategy for characterization of nanoscale621
particles by asymmetric-flow field flow fractionation: A tutorial, Anal Chim Acta. 809 (2014) 9-24.622
[20] S.K. Ratanathanawongs, D.L. Williams, Field-flow fractionation of proteins, polysaccharides, synthetic623
polymers, and supramolecular assemblies, J Sep Sci. 29 (2006) 1720-1732.624
[21] K.-G. Wahlund, Flow field-flow fractionation: critical overview, J Chromatogr A. 1287 (2013) 97-112.625
[22] B. Roda, A. Zattoni, P. Reschiglian, M.H. Moon, M. Mirasoli, E. Michelini, A. Roda, Field-flow626
fractionation in bioanalysis: a review of recent trends, Anal Chim Acta. 635 (2009) 132-143.627
[23] F.A. Messaud, R.D. Sanderson, J.R. Runyon, T. Otte, H. Pasch, S.K.R. Williams, An overview on field-flow628
fractionation techniques and their applications in the separation and characterization of polymers, Prog629
Polym Sci. 34 (2009) 351-368.630
[24] G. Yohannes, M. Jussila, K. Hartonen, M.-L. Riekkola, Asymmetrical flow field-flow fractionation631
technique for separation and characterization of biopolymers and bioparticles, J Chromatogr A. 1218 (2011)632
4104-4116.633
[25] M. Baalousha, B. Stolpe, J. Lead, Flow field-flow fractionation for the analysis and characterization of634
natural colloids and manufactured nanoparticles in environmental systems: a critical review, J Chromatogr635
A. 1218 (2011) 4078-4103.636
[26] J.C. Giddings, F.J. Yang, M.N. Myers, Flow field-flow fractionation: new method for separating,637
purifying, and characterizing the diffusivity of viruses, J Virol. 21 (1977) 131-138.638
[27] Y.P. Chuan, Y.Y. Fan, L. Lua, A.P. Middelberg, Quantitative analysis of virus-like particle size and639
distribution by field-flow fractionation, Biotechnol Bioeng. 99 (2008) 1425-1433.640
[28] T. Bousse, D.A. Shore, C.S. Goldsmith, M.J. Hossain, Y. Jang, C.T. Davis, R.O. Donis, J. Stevens,641
Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying642
influenza A particles, J Virol Methods. 193 (2013) 589-596.643
[29] Z. Wei, M. Mcevoy, V. Razinkov, A. Polozova, E. Li, J. Casas-Finet, G.I. Tous, P. Balu, A.A. Pan, H. Mehta,644
Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle645
light scattering: correlation of particle counts, size distribution and infectivity, J Virol Methods. 144 (2007)646
122-132.647
[30] D. Lipin, Y. Chuan, L. Lua, A. Middelberg, Encapsulation of DNA and non-viral protein changes the648
structure of murine polyomavirus virus-like particles, Arch Virol. 153 (2008) 2027-2039.649
[31] A. Citkowicz, H. Petry, R.N. Harkins, O. Ast, L. Cashion, C. Goldmann, P. Bringmann, K. Plummer, B.R.650
Larsen, Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow651
fractionation and light scattering, Anal Biochem. 376 (2008) 163-172.652
[32] R. Lang, G. Winter, L. Vogt, A. Zürcher, B. Dorigo, B. Schimmele, Rational design of a stable, freeze-653
dried virus-like particle-based vaccine formulation, Drug Dev Ind Pharm. 35 (2009) 83-97.654
[33] R.H. Olsen, J.S. Siak, R.H. Gray, Characteristics of PRD1, a plasmid-dependent broad host range DNA655
bacteriophage, J Virol. 14 (1974) 689-699.656
27
[34] L. Walin, R. Tuma, G.J. Thomas, D.H. Bamford, Purification of viruses and macromolecular assemblies657
for structural investigations using a novel ion exchange method, Virology. 201 (1994) 1-7.658
[35] D.H. Bamford, J.K. Bamford, S.A. Towse, G.J. Thomas, Jr., Structural study of the lipid-containing659
bacteriophage PRD1 and its capsid and DNA components by laser Raman spectroscopy, Biochemistry. 29660
(1990) 5982-5987.661
[36] N.G. Abrescia, J.M. Grimes, H.M. Kivelä, R. Assenberg, G.C. Sutton, S.J. Butcher, J.K. Bamford, D.H.662
Bamford, D.I. Stuart, Insights into virus evolution and membrane biogenesis from the structure of the663
marine lipid-containing bacteriophage PM2, Mol Cell. 31 (2008) 749-761.664
[37] N.G. Abrescia, J.J. Cockburn, J.M. Grimes, G.C. Sutton, J.M. Diprose, S.J. Butcher, S.D. Fuller, C. San665
Martin, R.M. Burnett, D.I. Stuart, D.H. Bamford, J.K. Bamford, Insights into assembly from structural analysis666
of bacteriophage PRD1, Nature. 432 (2004) 68-74.667
[38] J.J. Cockburn, N.G. Abrescia, J.M. Grimes, G.C. Sutton, J.M. Diprose, J.M. Benevides, G.J. Thomas, Jr.,668
J.K. Bamford, D.H. Bamford, D.I. Stuart, Membrane structure and interactions with protein and DNA in669
bacteriophage PRD1, Nature. 432 (2004) 122-125.670
[39] N.S. Atanasova, A. Sencilo, M.K. Pietilä, E. Roine, H.M. Oksanen, D.H. Bamford, Comparison of lipid-671
containing bacterial and archaeal viruses, Adv. Vir. Res., 92 (2015) 1-61.672
[40] J.K. Bamford, D.H. Bamford, Large-scale purification of membrane-containing bacteriophage PRD1 and673
its subviral particles, Virology. 181 (1991) 348-352.674
[41] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein675
utilizing the principle of protein-dye binding, Anal Biochem. 72 (1976) 248-254.676
[42] V.M. Olkkonen, D.H. Bamford, Quantitation of the adsorption and penetration stages of bacteriophage677
φ6 infection, Virology. 171 (1989) 229-238.678
[43] Z. Kuklenyik, M.S. Gardner, B.A. Parks, D.M. Schieltz, J.C. Rees, L.G. McWilliams, Y.M. Williamson, J.L.679
Pirkle, J.R. Barr, Multivariate DoE optimization of asymmetric flow field flow fractionation coupled to680
quantitative LC-MS/MS for analysis of lipoprotein subclasses, Chromatography. 2 (2015) 96-117.681
[44] M. Wagner, C. Pietsch, L. Tauhardt, A. Schallon, U.S. Schubert, Characterization of cationic polymers by682
asymmetric flow field-flow fractionation and multi-angle light scattering—a comparison with traditional683
techniques, J Chromatogr A. 1325 (2014) 195-203.684
[45] U.B. Kavurt, M. Marioli, W.T. Kok, D. Stamatialis, Membranes for separation of biomacromolecules and685
bioparticles via flow field-flow fractionation, J Chem Technol Biotechnol. 90 (2015) 11-18.686
[46] R. Lang, L. Vogt, A. Zürcher, G. Winter, Asymmetrical flow FFF as an analytical tool for the investigation687
of the physical stability of virus-like particles, LC GC North America. 27 (2009) 844-852.688
[47] N. Bendixen, S. Losert, C. Adlhart, M. Lattuada, A. Ulrich, Membrane–particle interactions in an689
asymmetric flow field flow fractionation channel studied with titanium dioxide nanoparticles, J Chromatogr690
A. 1334 (2014) 92-100.691
[48] M. Pontié, Effect of aging on UF membranes by a streaming potential (SP) method, Journal of692
membrane science. 154 (1999) 213-220.693
[49] J. Ashby, S. Schachermeyer, Y. Duan, L.A. Jimenez, W. Zhong, Probing and quantifying DNA–protein694
interactions with asymmetrical flow field-flow fractionation, J Chromatogr A. 1358 (2014) 217-224.695
[50] R.N. Qureshi, W.T. Kok, Optimization of asymmetrical flow field-flow fractionation (AF4), LC GC Europe.696
23 (2010) 5.697
[51] H. Oksanen, D. Bamford, Family Tectiviridae, in: M.J. Andrew M.Q. King, E.B.C. Adams, and Elliot J.698
Lefkowitz (Eds.) Virus Taxonomy. , Academic Press: London, UK, 2012, pp. 317-321.699
[52] J.T. Lis, R. Schleif, Size fractionation of double-stranded DNA by precipitation with polyethylene glycol,700
Nucleic Acids Res. 2 (1975) 383-390.701
[53] L. Pitkänen, P. Tuomainen, K. Eskelin, Analysis of plant ribosomes with asymmetric flow field-flow702
fractionation, Anal Bioanal Chem. 406 (2014) 1629-1637.703
[54] S. Melnikov, A. Ben-Shem, N.G. de Loubresse, L. Jenner, G. Yusupova, M. Yusupov, One core, two704
shells: bacterial and eukaryotic ribosomes, Nature Structural & Molecular Biology. 19 (2012) 560-567.705
706
28
Figure 1. Effect of focusing time on resolution and recovery.707
A) AF4 elution programmes with varying focusing times (tf).708
B) Representative fractograms for PEG-PRD1 samples (~5×1011 PFUs) with varying tf (tf709
was deducted from the time scale). Inset: void (V0) and first minor peaks. V0 eluted at ~1.8710
min. Signal intensity (V) was measured with UV-detector at 260 nm and 0.01 range setting.711
C) Protein composition of the first and second peak (~10 μg) compared to the same amount712
of PEG-PRD1 input sample and 1xPRD1 in a SDS-PAGE gel. Positions of standard proteins713
(M) and major PRD1 proteins are shown.714
715
Figure 2. AF4 fractionation of PEG-PRD1.716
A) Representative fractogram from AF4 analysis of a PEG-PRD1 sample (~8×1011 PFUs),717
tf (15 min) was deducted from the fractograms. Elution program is shown on the right y-axis718
(dashed red). UV-detector monitored UV-signal at 260 nm in volts (V) with a range setting719
of 0.01 (black solid line, left y-axis). V0 is the void.720
B) Absorbance measurements of fractions (1 ml, 5 min each). The two fractions having the721
highest absorbance values in the first and second peak are boxed.722
C) SDS-PAGE gel analysis of fractions 1-12 compared to 10 μg of the AF4 input sample723
PEG-PRD1, and 10 μg of 1xPRD1 used as purification control. Proteins were visualized with724
Coomassie stain. Positions of standard proteins (M) and major PRD1 proteins are shown.725
726
Figure 3. AF4 analysis of PRD1 lysate.727
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A) Representative fractogram from AF4 analysis of a PRD1 lysate sample (1 ml) containing728
~1.0×1011 PFUs. UV-detector monitored UV signal at 260 nm in volts (V) with a 0.001 range729
setting (blue line, left y-axis). Elution program is shown on the right y-axis (dashed red), tf730
(15 min) was deducted from the time scale. V0 is the void.731
B) Absorbance measurements of fractions (1 ml, 5 min each) from the beginning of elution.732
C) SDS-PAGE gels of pooled fractions representing the first and second peaks (marked with733
boxes in B), ~10 μg of 1xPRD1 as a purification control, and ~10 μg of PRD1 lysate (input734
sample). Proteins were visualized with Coomassie stain. Positions of standard proteins (M)735
and major PRD1 proteins are shown.736
737
Figure 4. AF4 analysis of PRD1 infection: one-step growth curve.738
A) Virus life cycle. Turbidity of PRD1 infected (blue) and uninfected cultures (red, dashed)739
was monitored at OD550. At time zero (OD550 ~0.8), cells were infected using a MOI of 10.740
At 20 min p.i., cells were washed to remove unadsorbed viruses. Since the infection was741
slow during the 50 min washing procedure at room temperature, those 50 min were742
deducted when displaying time on the x-axis. Coloured arrows indicate the time points743
analysed by AF4.744
B) Representative fractograms from analysis of culture supernatants (1 ml) collected at745
various time points from non-infected control cells. LB (Luria-Bertani media) control: the746
background signal from the growth media. UV-detector monitored UV signal at 260 nm in747
volts (V) with a 0.001 range setting (left y-axis). Elution program is shown on the right y-axis748
(dashed black). V0 is the void.749
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C) Representative fractograms from analysis of culture supernatants (1.0 ml) collected at750
various time points (min p.i.) from infected cells: 1 and 20 min p.i. (right y-axis); 115 and 185751
min p.i. (left y-axis). AF4 running conditions were the same as in B). Fractions (0.8 ml) were752
collected from the start of elution. V0 is the void.753
D) Two fractions with the highest A280 values from the first (19-23 min) and second (35-43754
min) peaks were pooled and their virus concentration (PFU/ml) assayed and compared to755
the input sample. Error bars: standard deviation from three AF4 runs.756
757
Figure 5. Sensitivity and maximal loading of PRD1.758
A) AF4 analysis of 1xPRD1 samples: 8.8 mg (~3.4×1013 PFUs) and a series of ten-fold759
dilutions from 3.3 mg to ~0.3 μg (1.4×1013 to ~1.4×109 PFU). The 15 min focusing step760
was followed by a 10 min linear ramp from 1 ml/min to 0 ml/min, tf was subtracted from the761
time scale (x-axis). Injection volume was 0.1 or 0.5 ml.762
B) SDS-PAGE gels of pooled fractions of the virus peak, fractions preceding the virus763
peak, and ~6 μg of 1xPRD1 input sample. Proteins were visualized with Coomassie stain.764
765
Figure 6. Particle size determination of PEG-PRD1.766
A) Fractograms of two independent AF4 analyses of PEG-PRD1 (~3×1010 PFUs). Samples767
were pretreated with DNase I. UV-detector monitored UV signal at 260 nm in volts (V) with768
a 0.001 range setting (solid lines, left y-axis). The elution program (dashed line, right y-axis)769
included a 25 min linear elution gradient that was followed by exponential decrease to 0.08770
ml/min; Vout was 0.5 ml/min. V0 is the void.771
31
772
B) Light scattering signal (LS90°) and size distribution (Rg) of PEG-PRD1 sample773
components. The inset shows the size distribution of virus particles in the peak eluting774
between 18-23 min. Rg values were determined using a sphere model for the virus peak and775
a random coil model for molecules eluting from ~28 min onwards.776
777
Figure 7. Tandem purification of PEG-PRD1 with AF4 and CIM anion exchange778
chromatography.779
A) Representative elugram of monolithic chromatography analysis. PEG-PRD1 was first780
fractionated by AF4, then pooled viral fractions (~3.4×1012 PFU, 1.4 mg) were applied to781
CIM 1-ml-QA column in 20 mM potassium phosphate pH 7.2, 1 mM MgCl2. Elution was782
performed using buffer supplemented with 2M NaCl using a linear 0–1.5 M NaCl gradient783
and flow rate of 1 ml/min. A280 values and NaCl concentration of the elution gradient are784
shown. 0.5 ml fractions were collected.785
B) SDS-PAGE gels of fractions 25-33. Proteins were visualized with Coomassie stain. M:786
protein standards; the most abundant PRD1 virion proteins are marked on the right.787
C) Protein concentration of fractions 22-35  and concentration of infectious viruses in788
fractions 25-35. Protein content of fractions marked with asterisks  was below the789




Table 1. Purification of PEG-PRD1 by AF4.
Input peak 1 peak 2
Volume (ml) 0.5 2.0 2.0
PFU/ml 1.5E+12 6.6E+07 1.8E+11
PFUs 7.6E+11 1.3E+08 3.7E+11
PFU yield (%) 100 0.02 49
Protein (μg/ml) 2333 37 37
Protein (μg) 1166 75 74
Protein yield (%) 100 6.4 6.3
PFU/mg protein 6.5E+08 1.8E+09 4.9E+12
A280/ml 12.8 0.52 0.46
A280 units 6.4 1.04 0.91
A280 yield (%) 100 16 14
PFU/A280 1.2E+11 1.3E+08 4.0E+11
Table 2. Purification of PRD1 lysate by AF4.
Input peak 1 peak 2
Volume (ml) 0.5 2.0 2.0
PFU/ml 1.9E+11 8.5E+06 2.8E+10
PFUs 9.5E+10 1.7E+07 5.5E+10
PFU yield (%) 100 0.02 58
Protein (μg/μl) 0.46 0.015 0.006
Protein (μg) 231 30.8 11.6
Protein yield (%) 100 13 5
PFU/mg protein 4.1E+11 5.5E+08 4.8E+12
A280/ml n.d. 0.16 0.06
A280 units n.d. 0.32 0.12
PFUs/A280 n.d. 5.4E+07 4.8E+11
n.d.,  not determined due to high absorbance values
of LB medium
Table 3. Minimal and maximal loading capacity for 1xPRD1. Protein and virus content of
pooled virus peaks were measured to monitor virus yield and purity, and for comparison with
the input sample (~1.4 × 1014 PFU/ml, 33 mg/ml, 4.1×1012 PFU/mg of protein).










(min) n PFU/ml PFUs
Yield








3300 1.4E+13 3 28.5 2 2.7E+12 8.1E+12 68 810 2430 74 3.3E+12 25 115 1.1E+11
330 1.4E+12 4 28.5 3 2.7E+11 1.1E+12 79 51 205 62 5.2E+12 2.4 107 1.1E+11
33 1.4E+11 4 27.8 3 2.2E+10 8.1E+10 60 n.d. n.d. n.d. n.d. 0.2 91 1.1E+11
3.3 1.4E+10 4 27.3 3 1.4E+09 5.8E+09 43   n.d. n.d. n.d. n.d. n.d. n.d. n.d.
n.d. A595 (Bradford) and A280 below detection limit
Table 4. Tandem AF4 - monolithic chromatographic purification of PEG-PRD1.
AF4 Input AF4 output, CIM
Input CIM Output
Volume (ml) 1.0 5.0 2.0
Average virus conc. (PFU/ml) 2.2E+13 6.8E+11 3.1E+12
Maximum virus conc. (PFU/ml) - - 5.5E+12
Total virus amount (PFU) 2.2E+13 3.4E+12 6.2E+12
Virus yield (PFU, %) 100% 15% -
Virus yield (PFU, %) 100% 182%
Average protein conc. (mg/ml) 3.6 0.29 0.25
Maximum protein conc. (mg/ml) - - 0.46
Total protein amount (mg) 3.6 1.5 0.50
Protein yield (mg, %) 100 42
Protein yield (mg, %) 100 33
Average specific infectivity (PFU/mg of protein) 6.1E11 2.3E+12 1.2E+13
Average protein conc. (A280/ml) 30.0 2.1 2.5
Maximum protein conc. (A280/ml) - - 4.3
Total protein amount (A280 units) 30.0 10.6 5.0
Protein yield (A280, %) 100 35
Protein yield (A280, %) 100 47
Average specific infectivity (PFU/A280 of protein) 3.2E+11 1.2E+12
CIM output calculated from the data presented in Fig. 7. Averages were calculated from fractions 26-29.



























Supplementary figure S1. PRD1 does not interact with the 100 kDa RC membrane.
A) AF4 elution programs without applied cross-flow (solid black) or with linear elution gradient
(red dashed). Vout was 0.2 ml/min. Tf was 15 min.
B) Representative AF4 fractograms of 1xPRD1 (~2.2×1012 PFU) analyzed with or /without
applied cross-flow. Tf (15 min) was deducted from the time scale. UV-detector monitored UV
signal at 260 nm in volts (V) with a 0.01 range setting.
C) A280 measurements from collected fractions (each 1 ml, 5 min) and A280 recovery yields
















1 0-5 0.520 0.010
2 5-10 1.620 0.014
3 10-15 0.172 1.380
4 15-20 0.029 0.788
5 20-25 0.012 0.131































Supplementary figure S2: AF4 fractionation of standard proteins with varying molecular
weights. A) Fractograms of standard proteins (left y-axis) were compared to PEG-PRD1 sample
(right y-axis), tf (15 min) was deducted from the time scale. UV-detector monitored UV signal at
260 nm in volts (V). The 15 min linear elution program from 1 ml/min to 0.05 ml/min is shown
with dashed black line. Channel flow rate (Vout) was 0.2 ml/min. B) Fractogram of a mixture of
225 and 447 kDa standard proteins. The elution program is the same as in A) (dashed black
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Supplementary figure S3. Effect of cross-flow on PRD1 recovery and resolution.
A) AF4 elution programs with varying cross-flows. Focusing time (tf) was 15 min. Channel flow
(Vout) was 0.2 ml/min.
B) Representative fractograms of 1xPRD1 (~2×1011 PFUs) with varying cross-flow rates, tf
was deducted from the time scale. UV-detector monitored UV signal at 260 nm in volts (V)


















0.2 Vout 0.2 ml/min, Vc 1.0 ml/min
Vout 0.4 ml/min, Vc 2.0 ml/min















Vout 0.2 ml/min, Vc 1.0 ml/min
Vout 0.2 ml/min, Vc 1.5 ml/min
Vout 0.5 ml/min, Vc 1.0 ml/min






1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Vout 0.2 ml/min, Vc 1.0 ml/min
Vout 0.2 ml/min, Vc 1.5 ml/min
Vout 0.5 ml/min, Vc 1.0 ml/min
Vout 0.5 ml/min, Vc 1.5 ml/min














Peak 1 (fr 3-5) 1.5 2.6E+08 3.9E+08 0.1 0.50 0.75 15
Peak 2 (fr 6-10) 2.5 1.7E+11 4.3E+11 74 0.35 0.88 18 4.8E+11
peak 1 (fr 3-5) 1.5 2.6E+08 3.9E+08 0.1 0.54 0.81 17
Peak 2 (fr 6-10) 2.5 1.4E+11 3.5E+11 61 0.35 0.87 18 4.0E+11
Peak 1 (fr 4-9) 3.0 7.1E+07 2.1E+08 0.0 0.29 0.88 18
Peak 2 (fr 12-18) 3.5 1.3E+11 4.6E+11 79 0.32 1.12 23 4.1E+11
Peak 1 (fr 3-8) 3.0 3.9E+07 1.2E+08 0.0 0.32 0.95 20
Peak 2 (fr 11-17) 3.5 1.4E+11 4.8E+11 82 0.31 1.07 22 4.4E+11










Supplementary figure S4. Effect of channel (Vout) and cross-flow (Vc) rate on resolution.
A) Representative AF4 fractograms of PEG-PRD1 sample (~6×1011 PFUs). Elution program:
15 min focusing, followed by elution with a 10 min linearly decaying cross-flow gradient ramping
from 1.0 (solid, black) or 1.5 ml/min (dashed, black) to 0.1 ml/min; channel flow rate was 0.2 or
0.5 ml/min. UV-detector monitored UV signal at 260 nm in volts (V) with a 0.01 range setting.
V0 is the void peak that eluted at ~1 min (Vout 0.5 ml/min) or ~1.4 min (Vout 0.2 ml/min); tf was
deducted from the time scale.
B) A280 measurements of the fractions that were collected from the beginning of elution.
C) Virus and protein amounts of the peaks.
D) Representative AF4 fractograms from analysis of PRD1 lysate using flow conditions yielding
Vc/Vout ratio of 5.0. Elution program from 1 ml/min to 0.1 ml/min is shown with black dashed
line. UV-detector monitored UV signal at 260 nm in volts (V) with a 0.001 range setting. V0 is
the void peak; tf (15 min) was deducted from the time scale.
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Peak 1 2 4.8E+08 9.5E+08 0.05 72 0.14 6 6.6E+09 0.5 1.1 4 8.8E+08
Peak 2 4 4.9E+11 2.0E+12 107 87 0.35 14 5.6E+12 1.8 7.1 25 2.8E+11
Step 1 Peak 1 2 7.9E+08 1.6E+09 0.09 172 0.34 13 4.6E+09 0.6 1.3 5 1.2E+09
Peak 2 4 4.9E+11 2.0E+12 107 189 0.76 30 2.6E+12 1.9 7.4 26 2.6E+11
Step 2 Peak 1 2 1.7E+10 3.3E+10 1.8 212 0.42 17 7.8E+10 1.2 2.4 8 1.4E+10
Peak 2 4 5.9E+11 2.3E+12 128 215 0.86 34 2.7E+12 1.8 7.4 26 3.2E+11
Input 0.5 3.7E+12 1.8E+12 100 5100 2.55 100 7.2E+11 57 29 100 6.4E+10
Constant
& linear
Virus Protein (Bradford) Protein (A280)
Supplementary figure S5. Effect of elution gradient type on resolution and PRD1 recovery.
A) Elution programs: i) (linear) 5 min constant cross-flow followed by a 25 min linear elution gradient from 1
ml/min to 0.1 ml/min; ii) (step 1) 10 min ramp from 1 ml/min to 0.5 ml/min, followed by constant cross-flow for 10
min and 10 min ramp to 0.1 ml/min; iii) (step 2) 5 min ramp from 1 ml/min to 0.3 ml/min followed by constant
cross-flow for 10 min and then 10 min ramp to 0.1 ml/min.
B) Representative AF4 fractograms of PEG-PRD1 (~2×1012 PFUs). Tf was deducted from the time scale. UV-
detector monitored UV signal at 260 nm in volts (V) with a 0.01 range setting. V0 is the void peak.
C) A280 measurements of fractions collected from the beginning of elution.
D) SDS-PAGE gel analysis of proteins (10 μg) from pooled fractions 2-3 from the first peak, pooled fractions 5-
8 or 6-9 from the second peak, and the PEG-PRD1 input (10 μg). Proteins were visualized with Coomassie stain.
M: protein standards; purification control 1xPRD1 (10 μg) with the most abundant PRD1 virion proteins indicated.
E) Recovery and purity of AF4 purified PEG-PRD1 from assayed protein and virus content of pooled peak
fractions.
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Supplementary figure S6. AF4 analysis of DNAseI and RNAseA treated PRD1 samples.
Please, note that a 250 μm spacer was used. A) Representative fractograms are shown for
non-treated lysate and lysate (~3*1011 PFUs) that was treated with DNAse I (50 μg/ml) or
RNAse A (30 μg/ml) for 30 min at 37 ºC prior AF4 analysis. Equal volumes of lysates (1 ml)
were analysed. UV-detector monitored UV signal at 280 nm in volts (V) (left y-axis) and 0.001
range setting. Elution program is shown on the right y-axis (dashed black; tf of 5 min is not
shown); Vout was 0.2 ml/min. V0 is the void peak that eluted at ~1.5 min. B) Representative
fractograms are shown for PEG-NaCl-precipitated samples (~1.4*1011 PFUs) prepared from
non-treated lysate and DNAse I or RNAse A treated lysates. AF4 analysis was done as in A).
UV-range setting was 0.01.
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Figure S7. AF4 analysis of PRD1 infection: one-step growth curve using 250 μm spacer and RC with a 10
kDa MWCO.
A) Virus life cycle. Turbidity of PRD1 infected cultures was monitored at OD550. At time zero (OD550 ~0.8),
cells were infected using a MOI of 10. Coloured arrows indicate the time points analysed by AF4.
B) Representative fractograms from analysis of culture supernatants prior cell lysis. LB (Luria-Bertani media)
control: the background signal from the growth media. UV-detector monitored UV signal at 260 nm in volts
(V) with a 0.001 range setting (left y-axis). Elution program is shown on the right y-axis (dashed black); tf (15
min) was deducted from the time axis. Vout was 0.2 ml/min.
C) Selected fractograms from analysis of culture supernatants collected after the onset of cell lysis. Fractions
(0.8 ml) were collected. Please note the 20-fold difference in UV signal intensity scale (left y-axis) between
panels B and C.
D) Recovery and purity of AF4 fractionated culture supernatants as determined by comparison of the number
of infectious viruses and A280 values for fractions 3 eluting at 8-12 min versus the virus concentration of
corresponding input sample.
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0 0 0.76 0 0
1 1* 0.76 5.7E+09 1.4E+09 1.1E+09 20 4.0
2 40 1.03 6.9E+09 4.5E+08 3.6E+08 5 15.3 0.005
3 80 0.95 0.07
4 95 0.90 8.9E+10 6.5E+10 5.2E+10 58 1.4 0.13 5.2E+11
5 110 0.89 0.16
6 125 0.68 1.7E+11 2.0E+11 1.6E+11 94 0.9 0.23 8.8E+11
7 140 0.58 2.5E+11 1.6E+11 1.3E+11 52 1.5 0.22 7.3E+11
8 155 0.49 2.6E+11 2.0E+11 1.6E+11 62 1.3 0.25 8.2E+11
* infected MOI 10
Supplementary figure S8. Obtained fits based on the spherical fit showed good agreement of the model
across the complete peak. Sphere model fit for the PEG-PRD1 virus particle at the beginning of the UV-peak (tr
















































































prot A260/ml A280/ml A260/A280 PFU/A280
Lysate 2480 2480 3.3E+11 1 1 8.2E+14 100%
Resuspended PEG-precipitate 2480 30 0.012 2.4E+13 1 1 7.2E+14 88.0 7.9 3.0E+12
Cleared PEG-precipitat: supernatant 30 30 1.9E+13 1 1 5.7E+14 69.7 8.4 2.3E+12 295 168 1.76 1.13E+11
Cleared PEG-precipitat: pellet 1 1 4.2E+12 1 1 4.2E+12 0.5 4 1.1E+12
5-20% sucrose: light scattering zone; filled particles 15 120 8.0 1.6E+12 2 1 3.8E+14 46.9 0.12 1.3E+13
5-20% sucrose: light scattering zone: empty 15 68 4.5 1.3E+10 2 1 1.8E+12 0.2 0.06 2.2E+11
1xPRD1 pellet: filled particles 40 0.12 0.003 2.0E+14 2 3.0 1.4E+14 17.6 16.8 1.2E+13 152 112 1.36 1.79E+12
1xPRD1 pellet: empty particles 23 0.08 0.003 4.1E+12 2 3.0 1.9E+12 0.2 10.1 4.1E+11
20-70% sucrose: light scattering zone: filled particles 80 48 0.60 1.4E+12 2 1.5 2.0E+14 24.6 0.14 1.0E+13
20-70% sucrose: light scattering zone: empty particles 45 20 0.44 5.8E+10 2 1.5 3.5E+12 0.4 0.02 2.9E+12
2xPRD1 pellet; light scattering zone; filled particles 48 0.34 0.007 2.3E+14 2 1 1.6E+14 19.1 9.7 2.4E+13
2xPRD1 pellet; light scattering zone; empty particles 20 0.1 0.005 4.2E+12 2 1.0 8.4E+11 0.1 3.6 1.2E+12
*Conversion factor 1: Half (15 ml) of the PEG-NaCl precipitate was used for traditional ultracentrifugation method. The volumes were adjusted to 30 ml by multiplying the obtained virus and
protein concentrations by 2.
**Conversion factor 2: After 5-20% sucrose gradient centrifugation, ~2/3 of the light scattering zones of filled or empty PRD1 particles were pelleted to yield 1xPRD1. In addition ~1/3 was
used for further purification via 20-70% sucrose gradient purification to yield 2xPRD1.
Lysate (2480 ml)
PEG-NaCl precipitate (30 ml)
Differential centrifugation
(40 ml): 1xPRD1 (filled)
Differential centrifugation
(23 ml): 1xPRD1 (empty)
20-70% sucrose gradient (80 ml)
Differential centrifugation
(48 ml): 2XPRD1 (filled)
5-20% sucrose gradient (14 ml)
Filled particles (120 ml) Empty particles (68 ml)
20-70% sucrose gradient (45 ml)
Differential centrifugation
(20 ml): 2XPRD1 (empty)
Cleared PEG-NaCl precipitate (30 ml) A 4F  and anion exchange (15 ml)
Figure S9. Traditional virus purification by subsequent ultracentrifugation steps.
A) Flow chart for traditional ultracentrifugation purification method. The volumes of different steps from one
purification experiment are shown in parenthesis and were used in calculating the recoveries in B).
B) Virus concentrations, recoveries, and specific infectivities for different sub-steps of traditional purification.
Recoveries were calculated to mirror the situation, in which the whole PEG-PRD1 sample would have been
utilized to produce either 1xPRD1 or 2xPRD1.
C) Comparison of PEG-PRD1, 1xPRD1 and 2xPRD1 in Coomassie stained SDS-PAGE gel. Analysed protein
amounts were 5 and 10 μg.
A)
B)
C)
PEG-PRD1 1xPRD1 2xPRD1
